ARCpoint

ARCpoint EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of ARCpoint (ARC.V) as of Oct 24, 2026 is -84.60 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -116.32 % — a change of -27.27% (higher).

EBIT/Assets

-84.60 %

YoY

-27.27%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of ARCpoint is 2025 -84.60 % . Operating Income to Assets Ratio (EBIT/Assets) of ARCpoint was 2024 -116.32 % . It decreases by -27.27% higher compared to the previous year.

The ARCpoint EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2021
40.90 USD
Jan 1, 2022
-25.65 USD
Jan 1, 2023
-112.20 USD
Jan 1, 2024
-116.32 USD
Jan 1, 2025
-84.60 USD
The ARCpoint EBIT/Assets history
YEAREBIT/AssetsYoY
-84.60 %-27.27%
-116.32 %+3.67%
-112.20 %+337.51%
-25.65 %-162.71%
40.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ARCpoint Stock analysis

What does ARCpoint do? ARCpoint, Inc. generates revenue through its franchise system, which includes drug testing, alcohol screening, DNA, and clinical lab testing services. The ARCpoint Franchise segment sells franchises to individuals across the United States, providing marketing, technology, and training support. The AFG Services segment offers clinical testing, software services, and diagnostic testing kits to franchisees and other business-to-business customers. The Other segment operates corporate-owned labs that serve businesses, physicians, and customers directly. Revenue streams include franchise fees, sales of diagnostic kits, and corporate lab services. ARCpoint Franchise segment revenue comes from franchise sales and ongoing support services. AFG Services segment revenue is derived from clinical testing, software services, and direct sales of diagnostic kits to business customers. Corporate-owned labs in the Other segment provide clinical and diagnostic services to businesses, physicians, and end customers, contributing to overall revenue. The company's business model relies on a mix of franchise sales, service offerings, and direct B2B transactions. The company's primary customers are individuals purchasing franchises, businesses requiring clinical testing, and physicians seeking diagnostic services. Franchisees benefit from ARCpoint's marketing, technology, and training support. AFG Services targets businesses needing diagnostic kits and software solutions. Corporate-owned labs serve businesses, physicians, and end customers with comprehensive testing solutions. Revenue is generated through multiple channels within the company's segmented structure. ARCpoint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ARCpoint stock

Operating Income to Assets Ratio (EBIT/Assets) of ARCpoint is -84.60 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of ARCpoint changed from -116.32 % to -84.60 %, representing a -27.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) ARCpoint since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s ARCpoint with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ARCpoint

All Key Metrics — ARCpoint